The USFDA has approved Merck & Co’s anti-PD-1 therapy – Keytruda (pembrolizumab).
https://5gigs.com/keytruda-a-new-monotherapy-indication-of-merck-received-approval-form-fda/
The USFDA has approved Merck & Co’s anti-PD-1 therapy – Keytruda (pembrolizumab).
https://5gigs.com/keytruda-a-new-monotherapy-indication-of-merck-received-approval-form-fda/